What is the global market size of Cell Culture Media Market?

Global Cell Culture Media Market size was valued at USD 4.9 billion in 2021 and is poised to grow from USD 5.68 billion in 2022 to USD 18.63 billion by 2030, growing at a CAGR of 16% in the forecast period (2023-2030).

Who are the key vendors in the Global Cell Culture Media Market?

Global cell culture media market is highly fragmented by numerous small manufacturers. Some of the major manufacturers include- Thermo Fisher Scientific Inc., Merck KGaA. Danaher Corporation, and Sartorius AG. These manufacturers are majorly focusing on expanding the global growth of cell culture media with new product innovation. In order to provide industries with the most effective and economical solutions, these major market players are also continually concentrating on R&D. Besides, these companies offer a range of products in different applications to fulfill the required demand of consumers which is further contributing to healthy growth in the market. 'Thermo Fisher Scientific Inc.', 'Merck KGaA', 'GE Healthcare', 'Lonza Group AG', 'Corning Incorporated', 'BD (Becton, Dickinson and Company)', 'HiMedia Laboratories', 'Fujifilm Holdings Corporation (Irvine Scientific Sales Company)', 'CellGenix GmbH', 'PromoCell GmbH', 'Takara Bio, Inc.', 'Sera Scandia A/S', 'Bio-Rad Laboratories, Inc.', 'InVitria (Ventria Bioscience)', 'Biomimetics Sympathies AG', 'ZenBio, Inc.', 'Sartorius AG', 'Agilent Technologies, Inc.', 'Irvine Scientific', 'Atlanta Biologicals, Inc.'

What is the key driver of Global Cell Culture Media Market?

Due to ethical issues there is an increase in demand for animal component-free media and automated cell culture systems. In traditional methods animals were used for clinical trials before being used on humans. Many non-governmental organizations are protesting against such companies.

What is the key market trend for Global Cell Culture Media Market?

Due to COVID-19 pandemic, researchers are trying to understand the biology of different virus variants to develop new therapeutic methods. This started in laboratory experiments to understand whether a drug can stop the virus from replicating in cells in a dish or whether a vaccine is effective on the virus.

Which region accounted for the largest share in Global Cell Culture Media Market?

North America accounts for the largest share of the cell culture media market of about 39.6% across the globe due to the rise in research & development investment. The pharmaceuticals and biotechnology industry is deeply investing to find out new innovative solutions and enhance patient care. In the U.S Biotech startups have raised a total of USD 47 billion in 2021, and in 2022 USD 16 billion is raised till date. USA holds the highest share of about 90% in the region

Cell Culture Media Market Size, Share, Growth Analysis, By Type(Serum-Free Media (CHO Media, HEK 293 Media, BHK Media, VERO Cell Media), By Application(Biopharmaceutical Production (Monoclonal Antibody Production, Vaccine Production, Other Therapeutic Protein Production Applications), Diagnostics), By End User(Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Research & Academic Institutes, Other End Users), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35H2057 | Region: Global | Published Date: September, 2024
Pages: 213 | Tables: 168 | Figures: 79

Cell Culture Media Market News

Pfizer and Thermo Fisher Scientific Inc. announced in May 2023 that both the companies ventured into an agreement for the wider access of next-generation sequencing testing for breast and lung cancer in over 30 countries.
In January 2024 US based company, Merck, had introduced its first digital hub outside of the United States and Europe, the introduction having been Merck Digital Hub in Singapore. capabilities.
US-based, Agilent Technologies launched the Agilent SureSelect Cancer CGP Assay for somatic variant profiling for stretch sequencing of solid tumor types in April 2023.

Cell Culture Media Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Cell Culture Media Market size was valued at USD 5.2 billion in 2022 and is poised to grow from USD 6.23 billion in 2023 to USD 20.45 billion by 2031, growing at a CAGR of 16.02% during the forecast period (2024-2031).

The cell culture media market is highly consolidated, with the dominant share belonging to major players. In 2023, ThermoFisher Scientific and Danaher together accounted for the major cell culture media market share. The leading positions of these companies are due to the strong distribution network and their constant work on launching new products in to the market. In addition, such strategic decisions as mergers, acquisitions, or expansion of manufacturing sites also lead these players to more solid positions on the market. 'Thermo Fisher Scientific ', 'Merck KGAA ', 'Danaher ', 'Sartorius AG ', 'Corning Incorporated ', 'Fujifilm Holdings Corporation ', 'Lonza ', 'Becton, Dickinson and Company (BD) ', 'Stemcell Technologies ', 'Miltenyi Biotec ', 'Himedia Laboratories ', 'Biologos ', 'PromoCell GmbH ', 'InvivoGen ', 'Pan-Biotech ', 'Cellular Technology Limited ', 'Cyagen Biosciences ', 'Biowest ', 'Akron Biotech ', 'Kcell Biosciences'

Researchers across the globe have been engaged in innovative work aimed at developing new techniques to maximize the efficiency of cell culture media for diverse clinical applications. Observations have shown albumins to be integral during the manufacturing of life-saving monoclonal antibodies and recombinant proteins. Albumin binds and stabilizes an array of critical small molecules and ions, lending stability. Therefore, augmenting culture mediums with recombinant mammalian albumin supplements is anticipated to considerably spur market growth and boost product yields. It is projected that embracing these advanced technologies will further accelerate the expansion of the market throughout the projected period.

Increasing Acceptance for Gene Therapies: Gene therapy is applied for treating diverse acquired and inherited neurological diseases. Moreover, gene products are mentioned to lessen cellular dysfunction and have been validated as a novel therapeutic approach. In addition, several applications in gene therapy have emerged at the moment, while scientists globally are involved in R&D to uncover novel applications. This is expected to boost the demand for cell culture media.

North America retains the largest market share due to factors such as the presence of key manufacturers, a high prevalence of diseases which is creating significant demand for drugs and other medications, advancements in technologies found in the preclinical and clinical segment, the rise in health awareness among the population and high disposable income. According to The American Cancer Society, Inc., in 2020, approximately 1.9 million new cancer cases were diagnosed in the U.S. and approximately 609,360 deaths occurred. Factors such as this will increase the demand and growth of the market during the forecast period. 

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Cell Culture Media Market News

Cell Culture Media Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Cell Culture Media Market?

Who are the key vendors in the Cell Culture Media Market?

What is the key driver of Cell Culture Media Market?

What is the key market trend for Cell Culture Media Market?

Which region accounted for the largest share in Cell Culture Media Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300